- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07340255
The 90% Effective Ventilation Pressure (EP90) for Esophageal Insufflation Avoidance During Anesthesia Induction
The 90% Effective Ventilation Pressure (EP90) for Esophageal Insufflation Avoidance During Anesthesia Induction: A Bias-Coin Design With Up-and-Down Sequential Allocation Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pulmonary aspiration of gastric contents has been identified as one of the leading causes of anesthesia-related mortality. Even in fasting patients or those without known aspiration risks, such complications can still occur. In fact, in patients with unprotected airways during apnea, the introduction of air into the lungs during ventilation may become a potential trigger for gastric content aspiration. The entry of air can increase gastric pressure, leading to the reflux of gastric contents into the esophagus, which may subsequently result in hemodynamic instability and pulmonary failure. Therefore, airway management during anesthesia induction is crucial, particularly in the precise control of ventilation pressure, as it directly impacts the safety of the patient during surgery.
Previous studies have used gastric insufflation as the primary endpoint for evaluating the safety of ventilation pressures, often assessing the appearance of gastric gas in the stomach during mask ventilation. However, gastric insufflation typically occurs only after gas has passed through the esophagus and cardia, entering the gastric cavity-this process is a "terminal event" triggered by higher pressures. The esophagus, being structurally weaker than the stomach, is less tolerant to pressure. When gas first enters the esophagus, the cardia is not fully open, and if ventilation pressure continues to rise, it is easy to cause esophageal insufflation, further leading to gastric insufflation and even gastric content reflux. Since esophageal insufflation occurs earlier and has a lower pressure threshold, it can serve as a more sensitive indicator, providing an early warning to anesthesiologists about potential airway management issues.
To address this issue, determining the optimal ventilation pressure to avoid esophageal insufflation is particularly important. the 90% effective ventilation pressure (EP90) refers to the ventilation pressure that can avoid esophageal insufflation in 90% of cases, providing anesthesiologists with a quantitative reference for ventilation pressures.
This study employed a Sequential Allocation with Biased Coin Design (SABCD) trial, utilizing precise statistical methods to explore the EP90 for avoiding esophageal insufflation during anesthesia induction. The goal was to determine the optimal ventilation pressure for preventing esophageal insufflation during anesthesia induction and to explore its implications for anesthesia management. The ultimate aim is to provide a more precise and personalized ventilation pressure setting standard for clinical anesthesia, thereby enhancing the safety of the anesthesia induction phase.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Qinghe Zhou
- Phone Number: 13732573379
- Email: zqh10980@zjxu.edu.edu.cn
Study Locations
-
-
-
Jiaxing, China
- Recruiting
- Affiliated Hospital of Jiaxing University
-
Contact:
- Qinghe Zhou
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: 18-65 years, regardless of gender;
- ASA classification: I-III;
- Scheduled for elective general anesthesia surgery;
- BMI: 18.0-28.0 kg/m²;
- Preoperative fasting: Solid food >6 hours, liquid >2 hours;
- Less than two from five criteria predicting difficult mask ventilation as described by Langeron et al.(Prediction of difficult mask ventilation. Anesthesiology 2000; 92:1229-36);
- No severe underlying conditions such as heart, lung, liver, or kidney disease;
- Signed informed consent and ability to cooperate with the study protocol.
Exclusion Criteria:
- Pregnant or breastfeeding women;
- History of upper gastrointestinal diseases such as gastroesophageal reflux disease, peptic ulcers, or hiatal hernia;
- Recent (within 2 weeks) respiratory infections, chronic cough, similar symptoms, and other known or predictable respiratory system diseases;
- Need for emergency surgery or airway obstruction after anesthesia induction requiring urgent intubation;
- Inability to achieve adequate oxygenation during mask ventilation (e.g., SpO₂ < 92% for 30 seconds, unresponsive to treatment);
- History of contraindications or allergies to study medications;
- Inability to understand the study content or refusal to cooperate;
- Oropharyngeal or facial pathology;
- with an indwelling gastric tube, and who had previously undergone gastric surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Ventilation Pressure
Anesthesia machine settings: pressure control mode, inspiratory-to-expiratory ratio of 1:2, respiratory rate of 15 breaths/min, 100% oxygen, no PEEP applied.
Mask ventilation duration was standardized to 120 seconds, followed by tracheal intubation.
|
Before induction, during ventilation, and after intubation, the anesthesiologist used a 7-14 MHz linear array probe for transverse (supraclavicular) positioning to monitor the left paratracheal esophageal region in real time. The main criterion for assessment was the absence of esophageal gas during ventilation, which was considered a positive response. If gas was detected entering the esophagus on ultrasound, it was recorded as a negative response. Additionally, the anesthesiologist performed a preoperative ultrasound examination of the gastric antrum to record baseline gastric antrum parameters. After successful tracheal intubation, a follow-up ultrasound of the gastric antrum was conducted to obtain postoperative gastric antrum parameters. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
EP90
Time Frame: Perioperative
|
The 90% effective ventilation pressure (EP90) for avoiding esophageal inflation refers to the minimum effective airway pressure (measured in cmH₂O) at which 90% of patients do not experience esophageal inflation during pressure-controlled mask ventilation during anesthesia induction.
|
Perioperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
EP95
Time Frame: Periprocedural
|
The 95% effective ventilation pressure (EP95) for avoiding esophageal inflation refers to the minimum effective airway pressure (measured in cmH₂O) at which 95% of patients do not experience esophageal inflation during pressure-controlled mask ventilation during anesthesia induction.
|
Periprocedural
|
|
EP98
Time Frame: Periprocedural
|
The 98% effective ventilation pressure(EP98) for avoiding esophageal inflation refers to the minimum effective airway pressure (measured in cmH₂O) at which 98% of patients do not experience esophageal inflation during pressure-controlled mask ventilation during anesthesia induction.
|
Periprocedural
|
|
Ventilation-related respiratory parameters
Time Frame: Periprocedural
|
pulse oxygen saturation (SpO₂) was recorded at multiple time points during mask ventilation and 30/60/90/120 seconds after tracheal intubation.
|
Periprocedural
|
|
Ventilation-related respiratory parameters
Time Frame: Periprocedural
|
end-tidal carbon dioxide (EtCO₂) was recorded at multiple time points during mask ventilation and 30/60/90/120 seconds after tracheal intubation.
|
Periprocedural
|
|
Ventilation-related respiratory parameters
Time Frame: Periprocedural
|
end-tidal oxygen concentration (EtO₂) was recorded at multiple time points during mask ventilation and 30/60/90/120 seconds after tracheal intubation.
|
Periprocedural
|
|
Ventilation-related respiratory parameters
Time Frame: Periprocedural
|
minute leak volume was recorded at multiple time points during mask ventilation and 30/60/90/120 seconds after tracheal intubation.
|
Periprocedural
|
|
Ventilation-related respiratory parameters
Time Frame: Periprocedural
|
peak airway pressure (Ppeak) was recorded at multiple time points during mask ventilation and 30/60/90/120 seconds after tracheal intubation.
|
Periprocedural
|
|
Ventilation-related respiratory parameters
Time Frame: Periprocedural
|
tidal volume (Vt) was recorded at multiple time points during mask ventilation and 30/60/90/120 seconds after tracheal intubation.
|
Periprocedural
|
|
Incidence of complications Incidence of complications
Time Frame: Periprocedural
|
Including gastric distension, signs of aspiration, failure rate of mask ventilation [such as pulse oxygen saturation (SpO₂) < 92% lasting for 30 seconds], intubation condition score (Cormack-Lehane classification), hypoxemia and other adverse events.
|
Periprocedural
|
Collaborators and Investigators
Investigators
- Study Chair: Qinghe Zhou, Dr., Affiliated Hospital of Jiaxing University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025-KY-396
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Airway Management
-
Royal Hospital, OmanNot yet recruitingDifficult Airway | Obesity Difficult Airway Airway Management
-
Bursa City HospitalEmre ULUSOYNot yet recruitingAirway Management | Difficult AirwayTurkey (Türkiye)
-
Kutahya Health Sciences UniversityCompletedAirway Management | Difficult Airway | Difficult Airway IntubationTurkey (Türkiye)
-
NHS TaysideTerminated
-
Akdeniz University HospitalCompletedAirway Management | Difficult Airway | Obstetric AnesthesiaTurkey (Türkiye)
-
Diskapi Teaching and Research HospitalNot yet recruitingAirway ManagementTurkey (Türkiye)
-
Thomas RivaThe Hospital for Sick Children; Children's Hospital of Philadelphia; Charite... and other collaboratorsRecruitingAirway ManagementUnited States, Australia, Switzerland, Italy, Canada, Germany, Brazil
-
Peking Union Medical College HospitalNot yet recruiting
-
University of MalayaActive, not recruiting
-
Akdeniz UniversityCompletedAirway ManagementTurkey (Türkiye)
Clinical Trials on Ultrasonic and inflation determination
-
Universitat Jaume ICompleted
-
Zekai Tahir Burak Women's Health Research and Education...UnknownRespiratory Distress Syndrome
-
Nantes University HospitalCompleted
-
University of Texas Southwestern Medical CenterAstraZenecaTerminatedIschemic PreconditioningUnited States
-
Laval UniversityCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie...Active, not recruitingAortic Valve Stenosis | Cardiopulmonary BypassCanada
-
Cleveland Dental InstituteRecruiting
-
University of Medicine and Dentistry of New JerseyCompletedLiver Disease | Pancreas Disease | Kidney DiseaseUnited States
-
NinePoint MedicalCompletedUndergoing Esophagogastroduodenoscopy (EGD)United States
-
Escola Bahiana de Medicina e Saude PublicaCompletedDentin Sensitivity | Periodontal Disease
-
Zealand University HospitalCompleted